Key Financial Data Of Reporting Company

Kohjin Bio Co., Ltd. - Filing #7296611

Concept As at
2024-09-30
2024-04-01 to
2024-09-30
2023-04-01 to
2024-03-31
As at
2024-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
2,507,586,000 JPY
4,770,096,000 JPY
Ordinary profit (loss)
416,879,000 JPY
635,601,000 JPY
Net assets
5,279,427,000 JPY
3,342,393,000 JPY
Total assets
8,515,137,000 JPY
6,589,322,000 JPY
Basic earnings (loss) per share
55.70
92.43
Diluted earnings per share
Equity-to-asset ratio
0.620 xbrli:pure
0.507 xbrli:pure
Net cash provided by (used in) operating activities
518,146,000 JPY
823,681,000 JPY
Net cash provided by (used in) investing activities
-466,696,000 JPY
-577,354,000 JPY
Net cash provided by (used in) financing activities
1,485,818,000 JPY
-1,348,000 JPY
Cash and cash equivalents
3,306,780,000 JPY
1,726,936,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.